Publication: 3379

Publication: 3379

CODEL: Phase III study of RT alone, RT plus temozolomide, or temozolomide alone for newly diagnosed 1P/19Q codeleted anaplastic oligodendroglioma patients. Updated analysis from the initial study design (NCCTG N0577, Alliance)

URL

Google Scholar

Citation:: Neuro-oncology vol 22 (2) NP CTNI-29.

Meeting Instance:: SNO 2020
Year:: 2020
Type:: Abstract
Sub type:: Oral
Funding:: NCTN
Endpoint:: Primary
Analysis:: Other
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: ppub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: 2880

Program:: OGC
Primary Committee:: Neuro-Onc
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882, UG1CA233320, UG1CA233329, UG1CA232760; U10CA180820 (ECOG-ACRIN); U10CA180863 (CCTG); U10CA180868 (NRG)

Corr. Author:
Authors:: Kurt A. Jaeckle Karla V. Ballman Martin van den Bent Caterina Giannini Evanthia Galanis Paul D. Brown Robert B. Jenkins J Gregory Cairncross Wolfgang Wick Michael Weller Kenneth D. Aldape Jesse G. Dixon S. Keith Anderson Jane H. Cerhan Jeffrey S. Wefel Martin Klein Stuart A. Grossman David Schiff Frederick Dhermain Donald G. Nordstrom Patrick J. Flynn Michael A. Vogelbaum

Networks:: CA011, FL065, IA085, LAPS-MN026, LAPS-TX035, MN017, MN022, OH027, VA009

Study: NCCTG-N0577
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: